Endoscopic Ultrasonography Miniature Probe Performance for Depth Diagnosis of Early Gastric Cancer with Suspected Submucosal Invasion.
Endosonography
Invasion depth
Stomach neoplasms
Journal
Gut and liver
ISSN: 2005-1212
Titre abrégé: Gut Liver
Pays: Korea (South)
ID NLM: 101316452
Informations de publication
Date de publication:
15 09 2020
15 09 2020
Historique:
received:
17
07
2019
revised:
10
09
2019
accepted:
11
09
2019
pubmed:
10
12
2019
medline:
14
9
2021
entrez:
10
12
2019
Statut:
ppublish
Résumé
The accurate assessment of the depth of invasion of early gastric cancer (EGC) is critical to determine the most appropriate treatment option. However, it is difficult to distinguish shallow submucosal (SM1) invasion from deeper submucosal (SM2) invasion. We investigated the diagnostic performance of endoscopic ultrasonography (EUS) using a miniature probe for EGC with suspected SM invasion. From April 2008 to June 2018, EGCs with suspected SM invasion were analyzed retrospectively. The EGCs examined by a 20 MHz high-frequency miniature probe was included in our study. Esophago-gastric junction cancers and patients treated by chemotherapy before resection were excluded. The sensitivity and specificity for the detection of SM2 invasion by EUS were compared with those of white light imaging (WLI). Additionally, factors related to depth underestimation or overestimation were investigated using multivariate analysis. A total of 278 EGCs in 259 patients were included in the final analysis. The sensitivity and specificity for SM2 or deeper by EUS were 73.7% (87/118) and 74.4% (119/160), respectively. The sensitivity and specificity by WLI were 47.5% (56/118) and 68.1% (109/160), respectively. The sensitivity of EUS was significantly superior to that of conventional endoscopy (p<0.01). Multivariate analysis revealed that an anterior location of the EGC was an independent risk factor for underestimation by EUS (odds ratio, 3.3; 95% confidence interval, 1.1 to 9.8; p=0.03). The depth diagnostic performance for EGCs with suspected SM invasion using EUS was satisfactory and superior to that of conventional endoscopy. Additionally, it is important to recognize factors that may lead to misdiagnosis in those lesions.
Sections du résumé
Background/Aims
The accurate assessment of the depth of invasion of early gastric cancer (EGC) is critical to determine the most appropriate treatment option. However, it is difficult to distinguish shallow submucosal (SM1) invasion from deeper submucosal (SM2) invasion. We investigated the diagnostic performance of endoscopic ultrasonography (EUS) using a miniature probe for EGC with suspected SM invasion.
Methods
From April 2008 to June 2018, EGCs with suspected SM invasion were analyzed retrospectively. The EGCs examined by a 20 MHz high-frequency miniature probe was included in our study. Esophago-gastric junction cancers and patients treated by chemotherapy before resection were excluded. The sensitivity and specificity for the detection of SM2 invasion by EUS were compared with those of white light imaging (WLI). Additionally, factors related to depth underestimation or overestimation were investigated using multivariate analysis.
Results
A total of 278 EGCs in 259 patients were included in the final analysis. The sensitivity and specificity for SM2 or deeper by EUS were 73.7% (87/118) and 74.4% (119/160), respectively. The sensitivity and specificity by WLI were 47.5% (56/118) and 68.1% (109/160), respectively. The sensitivity of EUS was significantly superior to that of conventional endoscopy (p<0.01). Multivariate analysis revealed that an anterior location of the EGC was an independent risk factor for underestimation by EUS (odds ratio, 3.3; 95% confidence interval, 1.1 to 9.8; p=0.03).
Conclusions
The depth diagnostic performance for EGCs with suspected SM invasion using EUS was satisfactory and superior to that of conventional endoscopy. Additionally, it is important to recognize factors that may lead to misdiagnosis in those lesions.
Identifiants
pubmed: 31816675
pii: gnl19243
doi: 10.5009/gnl19243
pmc: PMC7492497
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
581-588Références
Gastric Cancer. 2017 Jan;20(1):1-19
pubmed: 27342689
Cochrane Database Syst Rev. 2015 Feb 06;(2):CD009944
pubmed: 25914908
J Gastric Cancer. 2011 Jun;11(2):109-15
pubmed: 22076211
Gastric Cancer. 2011 Mar;14(1):35-40
pubmed: 21327924
Acta Med Okayama. 2011 Apr;65(2):105-12
pubmed: 21519368
J Gastroenterol Hepatol. 2015 Nov;30(11):1566-73
pubmed: 26094975
Gastrointest Endosc. 1997 Sep;46(3):212-6
pubmed: 9378206
Gastroenterol Res Pract. 2012;2012:194530
pubmed: 23024651
World J Surg Oncol. 2012 Sep 15;10:190
pubmed: 22978534
Surg Endosc. 2019 Jul;33(7):2169-2180
pubmed: 30334157
Surg Endosc. 2018 Feb;32(2):855-863
pubmed: 28733747
Surg Endosc. 2011 Mar;25(3):841-8
pubmed: 20734082
World J Gastrointest Endosc. 2016 Aug 25;8(16):558-67
pubmed: 27621768
Gastrointest Endosc. 2011 May;73(5):917-27
pubmed: 21316050
J Gastrointest Oncol. 2017 Dec;8(6):1009-1017
pubmed: 29299361
Endoscopy. 1998 Aug;30 Suppl 1:A64-8
pubmed: 9765088
Gastroenterol Res Pract. 2012;2012:245390
pubmed: 23213325
Scand J Gastroenterol. 2017 Aug;52(8):864-869
pubmed: 28434266
J Clin Gastroenterol. 2009 Apr;43(4):318-22
pubmed: 19077733
Asian Pac J Cancer Prev. 2015;16(8):3141-5
pubmed: 25921111
World J Gastrointest Endosc. 2012 Jun 16;4(6):218-26
pubmed: 22720122
Medicine (Baltimore). 2016 Jul;95(30):e3955
pubmed: 27472672
J Gastroenterol Hepatol. 2010 Mar;25(3):506-11
pubmed: 20074167
Surg Endosc. 2018 Sep;32(9):3789-3797
pubmed: 29435750
Gastric Cancer. 2018 Jan;21(1):114-123
pubmed: 28224238